Bausch Health reported that international revenues grew due to growth in Canada, driven by its segment Salix.
3 reports, 2 independent
Updated Jul 30
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bausch Health reported that international revenues grew due to growth in Canada, driven by its segment Salix.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Bausch Health
multinational specialty drugs company based in Laval, Quebec, Canada
Nothing else this week.
-
Salix Pharmaceuticals
American specialty pharmaceutical company
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- themarketsdaily.com
- ACCESS NewswireBausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners For the Sixth Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 Scholarship
- Unknown outlet